These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7480621)

  • 1. An experiment in Tort reform.
    Flamberg G
    Public Health Rep; 1995; 110(5):635-8. PubMed ID: 7480621
    [No Abstract]   [Full Text] [Related]  

  • 2. The need for FDA regulation of tobacco products.
    Kennedy EM
    Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428
    [No Abstract]   [Full Text] [Related]  

  • 3. Congress examines childhood vaccine safety.
    Dove A
    Nat Med; 1999 Sep; 5(9):970. PubMed ID: 10471261
    [No Abstract]   [Full Text] [Related]  

  • 4. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives. Battle heats up over product liability reform.
    Miller D
    Faulkner Grays Med Health; 1995 Apr; 49(17):suppl 1-4. PubMed ID: 10141116
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B
    Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract]   [Full Text] [Related]  

  • 7. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
    Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory compliance preclusion of tort liability: limiting the dual-track system.
    Stewart RB
    Georgetown Law J; 2000 Jul; 88(7):2167-86. PubMed ID: 11503662
    [No Abstract]   [Full Text] [Related]  

  • 10. Taking on toys: states are charging ahead with new regulations on children's products even as the president takes action and industry cries foul.
    Boulard G
    State Legis; 2008; 34(9):30-3. PubMed ID: 18956495
    [No Abstract]   [Full Text] [Related]  

  • 11. States take the lead for safer toys.
    Haebler J
    Am Nurse; 2008; 40(3):13. PubMed ID: 18592874
    [No Abstract]   [Full Text] [Related]  

  • 12. Tort law deference to FDA regulation of medical devices.
    Green MD; Schultz WB
    Georgetown Law J; 2000 Jul; 88(7):2119-45. PubMed ID: 11503660
    [No Abstract]   [Full Text] [Related]  

  • 13. The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public?
    Levy E
    Fordham Law Rev; 2006 Mar; 74(4):2425-60. PubMed ID: 17115481
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical devices; preemption of state product liability claims--FDA. Correction.
    Fed Regist; 1997 Dec; 62(242):66179. PubMed ID: 10179302
    [No Abstract]   [Full Text] [Related]  

  • 15. The National Childhood Vaccine Injury Act and the supreme court's interpretation.
    Blake V
    Virtual Mentor; 2012 Jan; 14(1):31-4. PubMed ID: 23116914
    [No Abstract]   [Full Text] [Related]  

  • 16. Product recalls. Recalls: Evenflo expands recall of Majestic high chairs...and Evenflo recalls Envision high chairs.
    Child Health Alert; 2009 May; 27():6. PubMed ID: 19530269
    [No Abstract]   [Full Text] [Related]  

  • 17. Civil and criminal liability associated with food recalls.
    Packman JM
    Food Drug Law J; 1998; 53(3):437-52. PubMed ID: 10346721
    [No Abstract]   [Full Text] [Related]  

  • 18. MedChi to focus on public health and public safety in 2012 session.
    Ransom G
    Md Med; 2011; 12(4):23-5. PubMed ID: 22455214
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives. Product liability reform: an uphill battle.
    Olson EG
    Faulkner Grays Med Health; 1990 Feb; 44(7):suppl 4 p.. PubMed ID: 10103625
    [No Abstract]   [Full Text] [Related]  

  • 20. The Lohr decision: FDA perspective and position.
    Porter MJ
    Food Drug Law J; 1997; 52(1):7-11. PubMed ID: 10346705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.